Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC
Clinical trial NCT05131841 · UNKNOWN
Trial details
- NCT number
- NCT05131841
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-04
- Primary completion
- 2022-12-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.